The utility and advantages of exome and genome sequencing in pediatric kidney disease diagnosis
Childhood Kidney Diseases · 23.06.2026 · 30 (2) · 77-85
DOI: 10.3339/ckd.25.040 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Childhood Kidney Diseases, online erschienen am 23.06.2026. Verfasst von Seokhui Jang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics Division, 3billion Inc., Seoul, Republic of Korea. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Pediatric kidney diseases encompass a diverse group of disorders, ranging from congenital anomalies to glomerulopathies. Unlike adults, where lifestyle factors predominate, approximately 30% of pediatric cases constitute inherited kidney diseases. This high heritability underscores the critical importance of early and accurate genetic testing. While targeted gene panels have historically been the first-line diagnostic tool, they are limited by fixed gene content and an inability to detect complex structural variants. Next-generation sequencing, specifically exome sequencing and genome sequencing, has transformed the diagnostic landscape by enabling an unbiased, simultaneous analysis of all disease-associated genes. These modalities enhance diagnostic yields by identifying structural variants including copy number variants and non-coding variants often missed by conventional panels. Furthermore, they allow for the discovery of novel disease genes through periodic reanalysis. Despite these advancements, a significant diagnostic gap persists due to the limitations of short-read sequencing in complex genomic regions and the difficulty of interpreting variants of uncertain significance. To address these challenges, integrating long-read sequencing to resolve complex genomic regions and implementing systematic reanalysis protocols are recommended. This review provides a comprehensive comparison of diagnostic yields across testing modalities and discusses the future of genomic profiling in pediatric kidney diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Genetics Division, 3billion Inc., Seoul, Republic of Korea.
ORCID-Profile: Seokhui Jang, Hane Lee
Zitieren
APA
Jang, S., & Lee, H. (2026). The utility and advantages of exome and genome sequencing in pediatric kidney disease diagnosis. Childhood Kidney Diseases, 30(2), 77-85. https://doi.org/10.3339/ckd.25.040
Vancouver
Jang S, Lee H. The utility and advantages of exome and genome sequencing in pediatric kidney disease diagnosis. Childhood Kidney Diseases. 2026;30(2):77-85. doi:10.3339/ckd.25.040
BibTeX
@article{Jang2026,
author = {Jang, Seokhui and Lee, Hane},
title = {The utility and advantages of exome and genome sequencing in pediatric kidney disease diagnosis},
journal = {Childhood Kidney Diseases},
year = {2026},
volume = {30},
number = {2},
pages = {77--85},
doi = {10.3339/ckd.25.040}
}
EUVIMED